ER/PR pharmDx™ Kits
ER/PR pharmDx™ Kit is indicated as an aid in identifying patients eligible for treatment with anti-hormonal or aromatase inhibitor therapies as well as an aid in the prognosis and management of breast cancer.
Your Dako Account indicates that you are based in , you will be transfered to the web site for
Your basket was emptied because of the country change.
United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.
+41 41 760 11 66
+41 41 760 11 77